What Does the Economic Burden of Acute Myeloid Leukemia Treatment Look Like for the Next Decade? An Analysis of Key Findings, Challenges and Recommendations

Acute myeloid leukemia (AML) is conventionally treated with chemotherapy in eligible patients. Potentially curative regimens are associated with significant toxicity, and the major cost drivers in AML historically have been hospitalization and hematopoietic stem cell transplantation. The past severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Forsythe, Anna, Sandman, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107010/
https://www.ncbi.nlm.nih.gov/pubmed/33981169
http://dx.doi.org/10.2147/JBM.S279736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107010/
https://www.ncbi.nlm.nih.gov/pubmed/33981169
http://dx.doi.org/10.2147/JBM.S279736

Ejemplares similares